Advertisement

Index by author

May 01, 1989; Volume 35,Issue 5

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Abu-zeid, M
1. You have access
  Regulation of hepatic cortisol sulfotransferase in rats by pituitary growth hormone.
  Y Yamazoe, D Gong, N Murayama, M Abu-Zeid and R Kato
  
  Molecular Pharmacology May 1989, 35 (5) 707-712;
Asai, D J
1. You have access
  Selective inhibition of cytokinesis in sea urchin embryos by low concentrations of stypoldione, a marine natural product that reacts with sulfhydryl groups.
  E T O'Brien, D J Asai, R S Jacobs and L Wilson
  
  Molecular Pharmacology May 1989, 35 (5) 635-642;
Astroff, B
1. You have access
  Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies.
  M Harris, T Zacharewski, B Astroff and S Safe
  
  Molecular Pharmacology May 1989, 35 (5) 729-735;
Baba, M
1. You have access
  5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3'-fluoro-2',3'-dideoxy-5-chlorouridine.
  J Balzarini, A Van Aerschot, R Pauwels, M Baba, D Schols, P Herdewijn and E De Clercq
  
  Molecular Pharmacology May 1989, 35 (5) 571-577;
Balzarini, J
1. You have access
  5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3'-fluoro-2',3'-dideoxy-5-chlorouridine.
  J Balzarini, A Van Aerschot, R Pauwels, M Baba, D Schols, P Herdewijn and E De Clercq
  
  Molecular Pharmacology May 1989, 35 (5) 571-577;
2. You have access
  Differential inhibitory effects of several pyrimidine 2',3'-dideoxynucleoside 5'-triphosphates on the activities of reverse transcriptase and various cellular DNA polymerases.
  K Ono, H Nakane, P Herdewijn, J Balzarini and E De Clercq
  
  Molecular Pharmacology May 1989, 35 (5) 578-583;
Beitner, D B
1. You have access
  A novel action of morphine in the rat locus coeruleus: persistent decrease in adenylate cyclase.
  D B Beitner, R S Duman and E J Nestler
  
  Molecular Pharmacology May 1989, 35 (5) 559-564;
Beveridge, A J
1. You have access
  Molecular modelling of DNA-antitumour drug intercalation interactions: correlation of structural and energetic features with biological properties for a series of phenylquinoline-8-carboxamide compounds.
  R McKenna, A J Beveridge, T C Jenkins, S Neidle and W A Denny
  
  Molecular Pharmacology May 1989, 35 (5) 720-728;
Billedeau, R J
1. You have access
  A new class of mechanism-based inhibitors of transglutaminase enzymes inhibits the formation of cross-linked envelopes by human malignant keratinocytes.
  J J Killackey, B J Bonaventura, A L Castelhano, R J Billedeau, W Farmer, L DeYoung, A Krantz and D H Pliura
  
  Molecular Pharmacology May 1989, 35 (5) 701-706;
Blair, T A
1. You have access
  Development of pharmacological sensitivity to adenosine analogs in embryonic chick heart: role of A1 adenosine receptors and adenylyl cyclase inhibition.
  T A Blair, M Parenti and T F Murray
  
  Molecular Pharmacology May 1989, 35 (5) 661-670;
Bloom, S E
1. You have access
  Evidence for a PCN-P450 enzyme in chickens and comparison of its development with that of other phenobarbital-inducible forms.
  N A Lorr, S E Bloom, S S Park, H V Gelboin, H Miller and F K Friedman
  
  Molecular Pharmacology May 1989, 35 (5) 610-616;